Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)
暂无分享,去创建一个
T. Similowski | J. Timsit | É. Azoulay | A. Demoule | N. Pattison | Michel Durand | C. Guérin | M. Soares | P. Caruso | A. Duguet | P. Bachetti | J. Mayaux | C. Piras | F. Blot | V. Lemiale | G. Schettino | U. V. Silva | M. Zamboni | A. Toffart | U. V. Silva | F. Wallet | J. Delemazure | J. Timsit | G. Bourdin | A. Rabbat | A. Lefebvre | A. Parrot | C. Irrazábal | J. Salluh | L. Azevedo | B. Raynard | C. Lamer | G. Dessertaine | G. Burghi | M. Durand | A. Sousa | V. Souza-Dantas | C. Barth | L. C. Azevedo | Nivia Estuardo | E. Tobar | B. Almeida | Guilherme Schettino | Natalie Pattison | G. Burghi | C. Irrazabal | N. Pattison | U. V. Silva | A. Rabbat | C. Lamer | A. Parrot | V. C. Souza-Dantas | F. Wallet | F. Blot | G. Bourdin | J. Delemazure | Célica Pierina Vicente C. Mauro M. Aureliano Bruno F. C. Irrazábal Bachetti Souza-Dantas Zamboni So | Célica Irrazábal | Vicente C. Souza-Dantas | Bruno F. C. Almeida | L. S. Santos | Ulysses V. A. Silva | S. Piras | Albano S. M. T. Silva | François Blot | Antoine Parrot | Florent Wallet | Christian Lamer | Julie Delemazure | Pr Jean François Payen | Gael Bourdin | Antoine Rabbat | Gastón Burghi | U. Silva | Bruno F. C. Almeida | A. Rabbat | F. Blot | J. Timsit | M. Durand | E. Azoulay | C. Irrazábal | N. Pattison | E. Tobar | L. C. Azevedo | C. Lamer | A. Parrot | F. Wallet | C. Irrazábal | N. Pattison | E. Tobar | L. C. Azevedo | É. Azoulay
[1] M. Boubaya,et al. In-hospital and day-120 survival of critically ill solid cancer patients after discharge of the intensive care units: results of a retrospective multicenter study—A Groupe de recherche respiratoire en réanimation en Onco–Hématologie (Grrr-OH) study , 2018, Annals of Intensive Care.
[2] S. Marsch,et al. Oncological patients in the intensive care unit: prognosis, decision-making, therapies and end-of-life care. , 2017, Swiss medical weekly.
[3] Xueyan Yu,et al. EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer , 2017, Oncotarget.
[4] J. Shih,et al. Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit , 2017, Journal of Cancer.
[5] É. Azoulay,et al. Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms , 2017, Critical care medicine.
[6] R. Beale,et al. Short-term and medium-term survival of critically ill patients with solid tumours admitted to the intensive care unit: a retrospective analysis , 2016, BMJ Open.
[7] B. Robinson,et al. Immunotherapy for lung cancer , 2016, Respirology.
[8] M. Soares,et al. ICU severity of illness scores: APACHE, SAPS and MPM , 2014, Current opinion in critical care.
[9] K. Puxty,et al. Survival in solid cancer patients following intensive care unit admission , 2014, Intensive Care Medicine.
[10] J. Timsit,et al. Intensive care in patients with lung cancer: a multinational study. , 2014 .
[11] Jae Ho Lee,et al. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB–IV lung cancer patients , 2014, Medical Oncology.
[12] D. de Ruysscher,et al. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] Ioanna Kougioumtzi,et al. Intensive care unit and lung cancer: when should we intubate? , 2013, Journal of thoracic disease.
[14] J. Wisnivesky,et al. Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit. , 2011, Lung cancer.
[15] R. Wiener,et al. Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results-medicare registry. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Pastores,et al. Intensive care of the cancer patient: recent achievements and remaining challenges , 2011, Annals of intensive care.
[17] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[18] P. Ancel,et al. Six-month prognosis of patients with lung cancer admitted to the intensive care unit , 2009, Intensive Care Medicine.
[19] C. Sprung,et al. Characteristics and outcomes of cancer patients in European ICUs , 2009, Critical care.
[20] P. Ingrand,et al. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] C. Ferreira,et al. Prognosis of lung cancer patients with life-threatening complications. , 2007, Chest.
[22] A. Soubani,et al. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit , 2006, European Respiratory Journal.
[23] C. Reichner,et al. Outcome and code status of lung cancer patients admitted to the medical ICU. , 2006, Chest.
[24] N. Christakis,et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Jean-François Timsit,et al. Predictors of intensive care unit refusal in French intensive care units: A multiple-center study* , 2005, Critical care medicine.
[26] M. Soares,et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study , 2004, Critical care.
[27] T. Tanvetyanon,et al. Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer , 2003, Critical care medicine.
[28] M. Rosenthal,et al. Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. , 2002, Lung cancer.
[29] S. Chevret,et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support , 2001, Critical care medicine.
[30] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[31] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[32] J. Studnicki,et al. Intensive care, survival, and expense of treating critically ill cancer patients. , 1993, JAMA.
[33] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[34] C. Hamard,et al. [News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)]. , 2016, Annales de pathologie.
[35] T. Cooksley,et al. Emergency oncology: development, current position and future direction in the USA and UK , 2016, Supportive Care in Cancer.
[36] M. Wislez,et al. Actualités sur les thérapies ciblées dans les cancers bronchiques non à petites cellules, hors immunothérapie , 2016 .
[37] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[38] N. Barbetakis,et al. Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure. , 2013, Hippokratia.
[39] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[40] J. Timsit,et al. Use of intensive care in patients with nonresectable lung cancer. , 2011, Chest.
[41] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.
[42] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[43] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.